Phase I trial of UGP 281.

Trial Profile

Phase I trial of UGP 281.

Planning
Phase of Trial: Phase I

Latest Information Update: 26 Sep 2012

At a glance

  • Drugs UGP 281 (Primary)
  • Indications Obesity
  • Focus Adverse reactions
  • Most Recent Events

    • 26 Sep 2012 Unigene has secured funding and is making preparations for an IND filing in 2013 according to a Unigene media release.
    • 09 Aug 2012 Plans for this trial have been put on hold due to funding issues according to a Unigene media release.
    • 22 May 2012 Planned initiation date changed from 1 Dec 2012 to 1 Jun 2013 as reported by Unigene laboratories.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top